What is a stock summary page? Click here for an overview.
Business Description
Intravenous Infusions Ltd
ISIN : GH0000001258
Share Class Description:
XGHA:IIL: Ordinary SharesCompare
Compare
Traded in other countries / regions
IIL.Ghana IPO Date
2015-04-08Description
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Piotroski F-Score | N/A/9 |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History |
---|
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Intravenous Infusions Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil GHS) | |||
EPS (TTM) (GHS) | - | ||
Beta | - | ||
3-Year Sharpe Ratio | -0.12 | ||
3-Year Sortino Ratio | -0.19 | ||
Volatility % | - | ||
14-Day RSI | - | ||
14-Day ATR (GHS) | - | ||
20-Day SMA (GHS) | 0.05 | ||
12-1 Month Momentum % | - | ||
52-Week Range (GHS) | 0.05 - 0.05 | ||
Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Intravenous Infusions Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Intravenous Infusions Ltd Stock Events
Event | Date | Price (GHS) | ||
---|---|---|---|---|
No Event Data |
Intravenous Infusions Ltd Frequently Asked Questions
What is Intravenous Infusions Ltd(XGHA:IIL)'s stock price today?
The current price of XGHA:IIL is GHS0.05. The 52 week high of XGHA:IIL is GHS0.05 and 52 week low is GHS0.05.
When is next earnings date of Intravenous Infusions Ltd(XGHA:IIL)?
The next earnings date of Intravenous Infusions Ltd(XGHA:IIL) is .
Does Intravenous Infusions Ltd(XGHA:IIL) pay dividends? If so, how much?
Intravenous Infusions Ltd(XGHA:IIL) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |